Sucuoğlu İşleyen, Z.; Muğlu, H.; Alaca Topçu, Z.; Beşiroğlu, M.; Yasin, A.İ.; Topçu, A.; Şimşek, M.; Şeker, M.; Türk, H.M.
Factors Affecting the Survival of Metastatic Breast Cancer Patients Treated with CDK 4/6 Inhibitors. Medicina 2025, 61, 1279.
https://doi.org/10.3390/medicina61071279
AMA Style
Sucuoğlu İşleyen Z, Muğlu H, Alaca Topçu Z, Beşiroğlu M, Yasin Aİ, Topçu A, Şimşek M, Şeker M, Türk HM.
Factors Affecting the Survival of Metastatic Breast Cancer Patients Treated with CDK 4/6 Inhibitors. Medicina. 2025; 61(7):1279.
https://doi.org/10.3390/medicina61071279
Chicago/Turabian Style
Sucuoğlu İşleyen, Zehra, Harun Muğlu, Zeynep Alaca Topçu, Mehmet Beşiroğlu, Ayşe İrem Yasin, Atakan Topçu, Melih Şimşek, Mesut Şeker, and Hacı Mehmet Türk.
2025. "Factors Affecting the Survival of Metastatic Breast Cancer Patients Treated with CDK 4/6 Inhibitors" Medicina 61, no. 7: 1279.
https://doi.org/10.3390/medicina61071279
APA Style
Sucuoğlu İşleyen, Z., Muğlu, H., Alaca Topçu, Z., Beşiroğlu, M., Yasin, A. İ., Topçu, A., Şimşek, M., Şeker, M., & Türk, H. M.
(2025). Factors Affecting the Survival of Metastatic Breast Cancer Patients Treated with CDK 4/6 Inhibitors. Medicina, 61(7), 1279.
https://doi.org/10.3390/medicina61071279
